PK time points [Design Issues]

posted by Vaibhav – India, 2022-06-23 23:31 (163 d 06:48 ago) – Posting: # 23077
Views: 495

Dear All,
Are the below sampling points adequate for PK profile?
Median Tmax - 6 days
Mean half life: 26 days
Sub cutaneous: single dose
2, 12 and 24 hrs after administration. Additional samples were collected on day 2, 4, 6, 8, 10, 14, 28, 42, 56, 84, 112 and 140 days.
I have taken these time points from an article available in public domain.
Is there any method to calculate sampling point apart from method mentioned in BABE guidelines?
It’s a difficult to calculate time points for drug who has long Tmax and long half life.
Thank you in advance.


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,427 posts in 4,694 threads, 1,598 registered users;
14 visitors (0 registered, 14 guests [including 8 identified bots]).
Forum time: 05:20 CET (Europe/Vienna)

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5